- Home
- TRIB vs IBIO Comparison
TRIB vs IBIO Comparison
Compare TRIB & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- IBIO
- Stock Information
- Founded
- TRIB 1992
- IBIO 2008
- Country
- TRIB Ireland
- IBIO United States
- Employees
- TRIB N/A
- IBIO N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- IBIO Health Care
- Exchange
- TRIB Nasdaq
- IBIO Nasdaq
- Market Cap
- TRIB 13.0M
- IBIO 15.9M
- IPO Year
- TRIB N/A
- IBIO N/A
- Fundamental
- Price
- TRIB $0.74
- IBIO $0.82
- Analyst Decision
- TRIB
- IBIO Strong Buy
- Analyst Count
- TRIB 0
- IBIO 3
- Target Price
- TRIB N/A
- IBIO $4.87
- AVG Volume (30 Days)
- TRIB 2.4M
- IBIO 5.5M
- Earning Date
- TRIB 08-13-2025
- IBIO 05-02-2025
- Dividend Yield
- TRIB N/A
- IBIO N/A
- EPS Growth
- TRIB N/A
- IBIO N/A
- EPS
- TRIB N/A
- IBIO N/A
- Revenue
- TRIB $61,555,000.00
- IBIO $375,000.00
- Revenue This Year
- TRIB $13.51
- IBIO $36.00
- Revenue Next Year
- TRIB $13.14
- IBIO N/A
- P/E Ratio
- TRIB N/A
- IBIO N/A
- Revenue Growth
- TRIB 8.31
- IBIO 650.00
- 52 Week Low
- TRIB $0.48
- IBIO $0.64
- 52 Week High
- TRIB $3.44
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- TRIB 56.63
- IBIO 48.01
- Support Level
- TRIB $0.70
- IBIO $0.71
- Resistance Level
- TRIB $0.77
- IBIO $0.87
- Average True Range (ATR)
- TRIB 0.08
- IBIO 0.10
- MACD
- TRIB 0.01
- IBIO 0.02
- Stochastic Oscillator
- TRIB 60.45
- IBIO 38.86
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.